Clinical Studies Sponsored by AlloVir

Clinical Studies Sponsored by AlloVir

Clinical Studies Sponsored by University of Rome Tor Vergata

Clinical Studies Sponsored by Purdue University

Clinical Studies Sponsored by AstraZeneca

List of LightSmyth Technologies, Inc. patents

List of 480 Biomedical patents

Clinical Studies where

Trial Sponsor

is

	Name	Description	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
	‌ Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)		NCT02313857		2015	2018	Interventional
	‌ Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia		NCT04605484		March 22, 2021	October 20, 2022	Interventional
	‌ Most Closely Human Leukocyte Antigen (HLA)-Matched BK Virus-specific T Lymphocytes (Viralym-B)		NCT02313844		March 1, 2018	2019	Interventional
	‌ Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)		NCT02276820	‌ Adenovirus infection	December 7, 2017	2019	Interventional
	‌ ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus		NCT01570283		2012	2017	Interventional
	‌ Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant		NCT02108522	Infection	2014	2019	Interventional
	‌ Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant		NCT04693637	‌ Adenovirus infection	January 15, 2021	March 1, 2023	Interventional
	‌ Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell Transplant		NCT04933968		March 21, 2022	June 30, 2024	Interventional

8 results

0 selected

8 results

0 selected